This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $24,765.70 contract covers the delivery of 3,750 units of the branded oncology medication Oncaspar (pegaspargase) in 5 mL vials. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure this direct federal award. Through this and similar contracts, DMS Pharmaceutical Group has demonstrated its capability to provide a diverse array of prescription drugs, over-the-counter medications, biologics, and medical consumables to the Department of Defense.
Generated 3/30/25, 12:51 AM